Advancing Breast Health Detection

This document details best practices for integrating GE HealthCare's Invenia™ Automated Breast Ultrasound (ABUS) system into comprehensive breast care programs. It highlights how ABUS, as a key component of multi-modality screening, significantly improves early cancer detection, particularly for women with dense breast tissue, addressing limitations of traditional mammography.

Addressing Dense Breasts and Screening Needs

With the increasing awareness of breast density's impact on mammography sensitivity, the adoption of advanced imaging technologies like ABUS is crucial. This paper showcases real-world applications and benefits observed across various healthcare practices, including enhanced detection of mammography-occult cancers and improved patient outcomes.

Key Benefits and Clinical Integration

Case studies illustrate how Invenia™ ABUS supports efficient screening workflows, provides higher accuracy for dense breasts, and complements other modalities such as mammography, tomosynthesis, and MRI. Experts emphasize its value in both screening and diagnostic capacities, contributing to more personalized and effective patient care pathways.